BIOCRYST PHARMACEUTICALS, INC. (BCRX) Capital expenditures 2016–2025
BIOCRYST PHARMACEUTICALS, INC. (BCRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2.5MFY2025 · since FY2016: $5.3M → $2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5M | +119.6% |
| FY2024 | $1.1M | -48.2% |
| FY2023 | $2.2M | +60.5% |
| FY2022 | $1.4M | -43.4% |
| FY2021 | $2.4M | +364.0% |
| FY2020 | $514,000 | +49.9% |
| FY2019 | $343,000 | -6.3% |
| FY2018 | $366,000 | +11.6% |
| FY2017 | $328,000 | -93.8% |
| FY2016 | $5.3M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice